Smoking cessation strategies in vascular surgery

Seminars in Vascular Surgery

Volumn 28, Issue 2, 2015, Pages 80-85

  Spangler, Emily L ^a   Goodney, Philip P ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; VARENICLINE; NICOTINE GUM;

ARTICLE; CLINICAL EFFECTIVENESS; DOCTOR PATIENT RELATION; DRUG SAFETY; HUMAN; MEDICAL PRACTICE; PATIENT COUNSELING; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SURGICAL PATIENT; TELECONSULTATION; TOBACCO DEPENDENCE; VASCULAR SURGEON; VASCULAR SURGERY; ADVERSE EFFECTS; COUNSELING; HEALTH PERSONNEL ATTITUDE; POSTOPERATIVE COMPLICATIONS; PREVENTION AND CONTROL; PROCEDURES; RISK FACTOR; RISK REDUCTION; SMOKING; TOBACCO USE DISORDER; TREATMENT OUTCOME; VASCULAR DISEASES;

ATTITUDE OF HEALTH PERSONNEL; COUNSELING; HUMANS; PATIENT EDUCATION AS TOPIC; PHYSICIAN'S ROLE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME; VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES;

EID: 84952873152     PISSN: 08957967     EISSN: 15584518     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2015.10.001     Document Type: Article

References (53)

1. Hoel AW, Nolan BW, Goodney PP, et al. Vascular Study Group of New England. Variation in smoking cessation after vascular operations. J Vasc Surg 2013, 57:1338-1344. quiz 1344 e1-4.
2. Centers for Disease Control and Prevention. Early release of selected estimates based on data from the 2011 National Health Interview Survey. Published 2012. Available at:. Accessed January 16, 2014. http://www.cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201206_08.pdf.
3. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
4. Conen D, Everett BM, Kurth, et al. Smoking, smoking cessation, [corrected] and risk for symptomatic peripheral artery disease in women: a cohort study. Ann Intern Med 2011, 154:719-726.
5. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997, 29:1422-1431.
6. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003, 290:86-97.
7. Lindstrom D, Sadr Azodi O, Wladis A, et al. Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial. Ann Surg 2008, 248:739-745.
8. Møller AM, Villebro N, Pedersen T, Tønnesen H. Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial. Lancet 2002, 359(9301):114-117.
9. Prochaska JO, Goldstein MG. Process of smoking cessation. Implications for clinicians. Clin Chest Med 1991, 12:727-735.
10. Stead LF, Bultrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013, 5:CD000165.
11. Fiore MC, Jaen CR, Baker TB, et al. Clinical practice guideline. Treating tobacco use and dependence: 2008 update. Published May 2008. Available at:. Accessed November 3, 2015. http://dx.doi.org/http://bphc.hrsa.gov/buckets/treatingtobacco.pdf.
12. US Department of Health and Human Services. 2013 Annual Progress Report to Congress: National Strategy for Quality Improvement in Health Care. Published 2013. Available at:. Accessed January 24, 2014. http://www.ahrq.gov/workingforquality/nqs/nqs2013annlrpt.htm.
13. Hennrikus D, Joseph AM, Lando HA, et al. Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol 2010, 56:2105-2112.
14. Searight R. Realistic approaches to counseling in the office setting. Am Fam Physician 2009, 79:277-284.
15. Flocke SA, Antognoli E, Step MM, Marsh S, Parran T, Mason MJ. A Teachable Moment Communication Process for smoking cessation talk: description of a group randomized clinician-focused intervention. BMC Health Serv Res 2012, 12:109.
16. Winickoff JP, Nabi-Burza E, Chang Y, et al. Implementation of a parental tobacco control intervention in pediatric practice. Pediatrics 2013, 132:109-117.
17. Thomsen T, Tønnesen H, Møller AM. Effect of preoperative smoking cessation interventions on postoperative complications and smoking cessation. Br J Surg 2009, 96:451-461.
18. Chi YW, Jaff MR. Optimal risk factor modification and medical management of the patient with peripheral arterial disease. Catheter Cardiovasc Interv 2008, 71:475-489.
19. Faulkner KW, House AK, Castleden WM. The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust 1983, 1:217-219.
20. Lassila R, Lepantalo M. Cigarette smoking and the outcome after lower limb arterial surgery. Acta Chir Scand 1988, 154:635-640.
21. Crouse JR, Hagaman AP. Smoking cessation in relation to cardiac procedures. Am J Epidemiol 1991, 134:699-703.
22. Gjeilo KH, Stenseth R, Klepstad P, Lydersen S, Wahba A. Patterns of smoking behaviour in patients following cardiac surgery. A prospective study. Scand Cardiovasc J 2010, 44:295-300.
23. Vidrine JI, Shete S, Cao Y, et al. Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med 2013, 173:458-464.
24. Drehmer JE, Ossip DJ, Rigotti NA, et al. Pediatrician interventions and thirdhand smoke beliefs of parents. Am J Prev Med 2012, 43:533-536.
25. Baggett TP, Rigotti NA. Cigarette smoking and advice to quit in a national sample of homeless adults. Am J Prev Med 2010, 39:164-172.
26. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med 2008, 168:1950-1960.
27. Solberg LI, Hollis JA, Stevens VJ, et al. Does methodology affect the ability to monitor tobacco control activities? Implications for HEDIS and other performance measures. Prev Med 2003, 37:33-40.
28. Fiore MC. Smoking Cessation Clinical Practice Guideline 1996, Agency for Health Care Policy and Research, Public Health Service, US Dept of Health and Human Services, Rockville, MD.
29. Spangler EL PC124 characteristics of patients enrolling in VAPOR: an SVS-sponsored trial of smoking cessation intervention. J Vasc Surg 2015, 61(suppl S):151S. on behalf of the VAPOR Investigators.
30. Lichtenstein E, Glasgow RE, Lando HA, Ossip-Klein DJ, Boles SM. Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res 1996, 11:243-257.
31. Ossip-Klein DJ, Giovino GA, Megahed N, et al. Effects of a smoker's hotline: results of a 10-county self-help trial. J Consult Clin Psychol 1991, 59:325-332.
32. An LC, Betzner A, Schillo B, et al. The comparative effectiveness of clinic, work-site, phone, and web-based tobacco treatment programs. Nicotine Tob Res 2010, 12:989-996.
33. Lichtenstein E, Glasgow RE. Smoking cessation: what have we learned over the past decade?. J Consult Clin Psychol 1992, 60:518-527.
34. Reed MB, Anderson CM, Vaughn JW, Burns DM. The effect of over-the-counter sales of the nicotine patch and nicotine gum on smoking cessation in California. Cancer Epidemiol Biomarkers Prev 2005, 14:2131-2136.
35. Syed BA, Chaudhari K. Smoking cessation drugs market. Nat Rev Drug Discov 2013, 12:97-98.
36. Vogt F, Hall S, Marteau TM. General practitioners' beliefs about effectiveness and intentions to prescribe smoking cessation medications: qualitative and quantitative studies. BMC Public Health 2006, 6:277.
37. Frishman WH, Ky T, Ismail A. Tobacco smoking, nicotine, and nicotine and non-nicotine replacement therapies. Heart Dis 2001, 3:365-377.
38. Haustein KO, Krause J, Haustein H, Rasmussen T, Cort N. Effects of cigarette smoking or nicotine replacement on cardiovascular risk factors and parameters of haemorheology. J Intern Med 2002, 252:130-139.
39. McRobbie H, Hajek P. Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 2001, 96:1547-1551.
40. Mohiuddin SM, Mooss AN, Hunter CB, Grollmes TL, Cloutier DA, Hilleman DE. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease. Chest 2007, 131:446-452.
41. Meine TJ, Patel MR, Washam JB, et al. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. Am J Cardiol 2005, 95:976-978.
42. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease. Arch Intern Med 1994, 154:989-995. Nicotine replacement therapy for patients with coronary artery disease.
43. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999, 340:685-691.
44. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 2006, 296:56-63.
45. Carson KV, Brinn MP, Robertson TA, et al. Current and emerging pharmacotherapeutic options for smoking cessation. Subst Abuse 2013, 7:85-105.
46. Polosa R, Morjaria JB, Caponnetto P, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med 2014, 9:537-546.
47. Polosa R, Caponnetto P, Maglia M, Morjaria JB, Russo C. Success rates with nicotine personal vaporizers: a prospective 6-month pilot study of smokers not intending to quit. BMC Public Health 2014, 14:1159.
48. Clarke JG, Stein LA, Martin RA, et al. Forced smoking abstinence: not enough for smoking cessation. JAMA Intern Med 2013, 173:789-794.
49. Stead LF, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 2007, 16(suppl 1):i3-i8.
50. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013, 8:CD002850.
51. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control 2007, 16(suppl 1):i53-i59.
52. Cummings KM, Hyland A, Fix B, et al. Free nicotine patch giveaway program 12-month follow-up of participants. Am J Prev Med 2006, 31:181-184.
53. Pomerleau O, Adkins D, Pertschuk M. Predictors of outcome and recidivism in smoking cessation treatment. Addict Behav 1978, 3:65-70.